INTRODUCTION
Tibial dyschondroplasia (TD) is the most prevalent skeletal abnormality associated with rapid growth; it results in deformed bones and lameness (Orth and Cook, 1994; Farquharson and Jefferies, 2000; Pines et al., 2005; Leach and Monsonego-Ornan, 2007) . The economic cost of TD, as manifested in the high rates of mortality, morbidity, and condemnation at the processing plant, is enormous. Also, birds with severe lesions are likely to be more susceptible to fractures during handling at the processing plant, which can increase the economic loss. In addition, lameness associated with TD is a serious animal welfare issue.
Longitudinal bone growth occurs in the growth plates located at the ends of long bones. The resting chondrocytes initially proliferate slowly and then accelerate their rate of proliferation along the longitudinal axis of the bone and form columns of cells. Ultimately, the most distal cells of the columnar layer stop proliferating, exit the cell cycle, and differentiate into hypertrophic chondrocytes. Proliferation and hypertrophy of chondrocytes, along with extracellular matrix (ECM) synthesis, are the main drivers of endochondral bone growth (Kronenberg, 2003; Beier, 2005; Provot and Schipani, 2005; Mackie et al., 2008) . The hypertrophic chondrocytes mineralize their ECM and undergo apoptosis or autophagy, and the region of hypertrophic cartilage is invaded by blood vessels (Burdan et al., 2009; Chagin and Sävendahl, 2009; Srinivas et al., 2009) . The capillary invasion mediated by vascular endothelial growth factor (VEGF) is a key mechanism for the precise coupling of chondrogenesis and osteogenesis (Gerber and Ferrara, 2000) , and any changes in this balance might induce pathological conditions (Gerber et al., 1999; Horton, 2003; Ortega et al., 2010) . The VEGF production by the hypertrophic chondrocytes is regulated by hypoxia and hypoxia-inducible factor-1α (HIF-1α; Schipani et al., 2001; Schipani, 2005; Araldi and Schipani, 2010) . This HIF-1α is the major regulator of the hypoxic responses and for formation of new blood vessels (Schipani et al., 2001; Provot and Schipani, 2005; Hickey and Simon, 2006) . Tibial dyschondroplasia is a disease of the growthplates that are located at the ends of the long bones (Pines and Hurwitz, 1991; Knopov et al., 1995; Farquharson and Jefferies, 2000; Pines et al., 2005) , and it is characterized by the appearance of a plug of unvascularized, unmineralized, opaque white cartilage that dominates the proximal metaphysis of the tibiatarsus and, occasionally, the tarsometatarsus (Hargest et al., 1985) . Tibial dyschondroplasia was attributed to abnormal differentiation of chondrocytes (Pines et al., 1998) , to changes in expression of genes encoding VEGF signaling (Rath et al., 2007) and to changes in matrix metalloproteinase (MMP) activities (Hasky-Negev et al., 2008; Dan et al., 2009; Velada et al., 2011) . Previously we demonstrated that, in contrast to the normal growthplates, those afflicted by TD were hypoxic and the expression level of HIF-1α was related to the severity of the disease (Genin et al., 2008) . The HIF-1α factor is one of the major client proteins of heat-shock protein 90 (Hsp90), which is required for the functioning and the rapid hypoxic stabilization of HIF-1α (Katschinski et al., 2004) . Heat-shock protein 90 is associated with inhibition of angiogenesis: it affects the VEGF/ VEGF-receptor system at various levels (Bohonowych et al., 2010; Staufer and Stoeltzing, 2010) , and various inhibitors of Hsp90 activity are currently evaluated in clinical trials as anti-angiogenic factors (Lancet et al., 2010; Ramanathan et al., 2010) . We demonstrated that Hsp90 and Hsp70 were expressed in the growth plate (Yalçin et al., 2007) and that, in the TD lesion hypoxia, led to increase in the transcription factor HIF-1α, thereby causing increases in the levels of Hsp 90 and 70 (Genin et al., 2008; Tian et al., 2009 ). Recently we demonstrated that administration of an Hsp90 inhibitor to TD-afflicted chicks resulted in reduction in growth-plate size and, contrary to its anti-angiogenic effect in tumors, occurrence of a major invasion of blood vessels into the growth plates. This was the result of upregulation of VEGF receptor Flk-1, one of the rate-limiting factors of vascularization in TD. In addition, the abnormal chondrocyte differentiation and the changes in HIF-1α were removed, which resulted in prevention of lameness (Herzog et al., 2011) . The Hsp90-inhibitor dosage and Hsp90 occupancy were suggested as reasons for the observed disparity between the Hsp90-dependent angiogenic responses of tumors and of avian growth plates (Ibrahim et al., 2005; Tillotson et al., 2010) .
Quercetin is a member of the bioflavonoid family and is found in fruits, vegetables, leaves, and grains. Like other bioflavonoids, quercetin has been shown to have anti-inflammatory, anticoagulative, and antihypertensive properties (Bucki et al., 2003; Perez-Vizcaino et al., 2006; Ishizawa et al., 2011, Mendoza and Burd, 2011) . In addition, within the bioflavonoid family, quercetin is the most potent scavenger of reactive oxygen species (Hanasaki et al., 1994) . Inhibition of Hsp synthesis (Hansen et al., 1997) , specifically of Hsp70 (Lee et al., 1994; Gonzalez et al., 2009; Bae et al., 2010 , Jung et al., 2010 , was suggested to be part of the mode of action of quercetin.
The first aim of the present study was to establish the dosage of Hsp90 inhibitor required for TD prevention. In addition, we used quercetin to evaluate the specificity of Hsp90 inhibition for TD prevention.
MATERIALS AND METHODS
All animal experiments were carried out according to the guidelines of the Volcani Center Institutional Committee for Care and Use of Laboratory Animals.
TD Induction and Hypoxia Determination
One-day-old male broiler chicks (Cobb strain) were raised in battery brooders at 24°C. The TD was induced by adding thiram to their feed at 40 ppm, from d 4 (Ben Bassat et al., 1999; Herzog et al., 2011) . Thiram-induced TD lesions differ from those in chicks afflicted by vitamin D deficiency. No decrease in parathyroid hormone (PTH)/PTHrP receptor gene expression and no reduction in plasma calcium, phosphorus, and 25(OH) 3 was observed in the thiram-induced growthplate lesions (Ben-Bassat et al., 1999; Herzog et al., 2011) . On the other hand, thiram induced the same pattern of gene expression and of chondrocytes differentiation as in field TD and in chicks selected for TD (Knopov et al., 1995; Pines et al., 1998; Praul et al., 2000; Genin et al., 2008) . The extension of the avascular plug into the metaphysis is dependent on the severity of the disease (Pines et al., 2005) . Growthplate hypoxia was evaluated in situ by injection of hypoxyprobe-1 (Chemicon International, Temecula, CA) into the wing vein at 40 mg/kg, according to Genin et al. (2008) . Various doses of the geldanamycin analog 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; InvivoGen, San Diego, CA), a specific inhibitor of Hsp90 activity (Tian et al., 2004) , were injected into the jugular vein on d 3 and 5 (1 d before and 1 d after thiram dietary addition) and chicks were eithanized on d 12. Quercetin (Sigma, St. Louis, MO) was added to the diet at 100 or 500 ppm 1 d before TD induction by thiram. The experiments were terminated on d 10 of age. The TD was scored according to Pines et al. (2005) . the tibiae were fixed in 4% paraformaldehyde. Immunohistochemistry was performed with VEGF receptor Flk-1 rabbit polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) at 1:50 dilution and alkaline phosphatase (AP) staining was performed according to Knopov et al. (1995) . Both Hsp90 and Hsp70 were detected by immunohistochemistry with monoclonal antibodies at 1:100 dilution, obtained from Abcam (Cambridge, UK) and Alexis Biochemicals (San Diego, CA), respectively. As a second antibody, we used goat anti-mouse immunoglobulin conjugated to horseradish peroxidase, and 3,3′-diaminobenzidine as a chromogen. No signal was observed without the primary antibody (Genin et al., 2008) .
RESULTS

Effect of 17-DMAG Dose on Thiram-Induced TD
Reduction in BW, growth-plate enlargement (Table  1 ; Figure 1 ), and lameness (Figure 2 ) are the major responses to thiram treatment. Administration of low doses of 17-DMAG (2 of 100 or 2 of 300 μg) to thiramtreated chicks caused slight but significant increases in BW (thiram group compare with those administered with 2 × 100 μg of 17-DMAG), without changes in TD scores, growth-plate width (Table 1; Figure 1 ), or lameness (Figure 2) . Administration of two 600-μg doses of 17-DMAG resulted in a greater increase in BW (compared with the untreated group) and a significant reduction in TD score, growth-plate width, and the chicks regained their ability to stand and walk properly, confirming our previous results (Herzog et al., 2011) . A higher dosage of 17-DMAG (2 doses of 900 μg) caused a further decrease in TD score and growth-plate width, which almost reverted to the controls levels. These chicks exhibited no signs of lameness, but a significant reduction in BW was observed. The dyschondroplasic growth plate is characterized by lack of vascularization and abnormal differentiation of chondrocytes along the bone axis, as indicated by absence of AP activity within the TD lesion (Figure 3 ). Low levels of 17-DMAG did not restore growth-plate vascularization or chondrocyte differentiation, whereas 2 doses of 600 μg or more resulted in a massive blood-vessel invasion into the growth plate, and re-established proper chondrocyte differentiation, as indicated by AP activity. At this point the treated growth plates became indistinguishable from the controls (Figure 3) . a-e Means in the same column and in the same experiment with no common superscript differ significantly (P < 0.05).
1 The results are the mean ± SE of 10 chicks. (17-DMAG) on growth-plate morphology. At the end of the experiment the tibial growth-plates were removed and photographed. A, control; B, thiram-induced tibial dyschondroplasia (TD); C, thiram-induced TD with 2 × 100 μg of 17-DMAG dosage; D, thiram-induced TD with 2 × 300 μg of 17-DMAG dosage; E, thiram-induced TD with 2 × 600 μg of 17-DMAG dosage; F, thiram-induced TD with 2 × 900 μg of 17-DMAG dosage. Note the enlarged growth plates in the chicks with TD before treatment. Low doses (2 × 100 and 2 × 300 μg) of 17-DMAG did not prevent growth-plate enlargement, whereas the high doses (2 × 600 and 2 × 900 μg) prevented the increase in lesion width. AC = articular cartilage; GP = growth plate. Magnification × 40. Color version available in the online PDF.
In the present study, the growth plates of the TDafflicted chicks exhibited downregulation of the VEGF receptor Flk-1 (Figure 4 ), confirming our previous results (Herzog et al., 2011) . Already the lowest dose of 17-DMAG used caused the Flk-1 level to increase to a value that did not differ from that of the controls, and higher doses did not cause any further changes in Flk-1 levels. The increase in Flk-1 level caused by low dosages of 17-DMAG preceded any changes in growth-plate histopathology, such as blood-vessel infiltration or proper chondrocyte differentiation.
Effect of Quercetin on Thiram-Induced TD
To examine the specificity of Hsp90 inhibition on TD progression, we used quercetin, an inhibitor of Hsp70 synthesis. Quercetin (at 100 or 500 ppm) was added to the diet that was fed to the chick 1 d before TD induc- tion by thiram. In the control chicks, both Hsp90 and Hsp70 were synthesized mainly by the chondrocytes of the hypertrophic zone. Addition of quercetin to the diet did not affect the level of Hsp90, but the high dosage resulted in decreased Hsp70 levels ( Figure 5 ). In the growth plates of the TD-afflicted chicks, increase in synthesis of both heat-shock proteins were observed, especially by chondrocytes of the proliferation zone. Quercetin had no effect on Hsp90 levels in the dyschondroplasic growth-plates, but it caused a dose-dependent decrease in the Hsp70 level.
In the control chicks, no effects of quercetin were observed on BW, growth-plate width, or lameness, regardless of the dosage (Table 1; Figure 6 ). In the TDafflicted chicks, quercetin did not prevent the reduction in BW or the increase in TD score, TD lesions, and lameness.
Quercetin is considered as one of the bioflavonoids with the highest antioxidative capacity (Rice-Evans et al., 1996; Kuhlmann et al., 1998) . However, in the present study, control chicks fed with quercetin exhibited mildly greater hypoxia than untreated chicks (compare Figure 7A with Figure 7B ,C), especially near to blood vessels. A major increase in hypoxia was observed in the TD lesions, and it was unaffected by quercetin.
DISCUSSION
In comparison with the mammalian growth plate, the avian one contains much longer columns of chondrocytes, with more cells in each zone, and the metaphyseal blood vessels penetrate more deeply; they extend to the articular cartilage, thereby making the avian growth plate much more vascular than the mammalian one (Leach and Gay, 1987; Pines and Hurwitz, 1991; Pines et al., 2005) . Although an oxygen-related gradient was observed within the normal chick growth plate, no hypoxia was detected and the oxygen status of the cells throughout the cartilage was consistent with their oxygen needs (Shapiro et al., 1997) . The decline in blood vessels observed in the TD lesion (Figure 3 ) resulted in hypoxia and changes in the expression level of HIF-1α, one of the client proteins of Hsp90 (Genin et al., 2008) . In contrast to the anti-angiogenic effect observed in mammals (Bohonowych et al., 2010; Staufer and Stoeltzing, 2010) , inhibition of Hsp90 activity caused a massive invasion of blood vessels into the TD lesions (Herzog et al., 2011) . In the angiogenesis assay of the chick chorioallantoic membrane, low doses of Hsp90 inhibitor were pro-angiogenic whereas high doses resulted in impaired and decreased blood-vessel formation (Tillotson et al., 2010) . By using a wide range of 17-DMAG concentrations, we ruled out the possibility that the inhibitor dosage and Hsp90 occupancy were among the reasons for the observed disparity between the angiogenic responses to Hsp90 inhibition in tumors and in avian growth plates. Low doses of 17-DMAG did not prevent thiram-induced TD, as indicated by TD score, TD lesion width, blood-vessel invasion, proper chondrocyte differentiation, and lameness (Table 1 ; Figures 1, 2, 3) . However, administration of 2 doses of 17-DMAG, each of 600 μg, prevented all signs of the TD lesion, whereas the highest dosage, although beneficial in preventing TD, caused reduction in chick BW. This may indicate that at high doses, 17-DMAG affects Hsp90 activity in additional tissues and becomes toxic, which results in the reduction in BW, similarly to that Figure 6 . Effects of quercetin on thiram-induced lameness and growth-plate size and morphology. At the end of the experiment, the chicks were photographed, and the tibial growth plates were removed, photographed, and stained with hematoxylin and eosin (H&E). Note the lameness and the enlarged growth plate in the chicks with tibial dyschondroplasia (TD), with and without quercetin. AC = articular cartilage; GP = growth plate; TDL = TD lesion; BV = blood vessels. Color version available in the online PDF. Figure 7 . Effects of quercetin on growth-plate hypoxia. Chicks were fed quercetin at 100 or 500 ppm, both with or without thiram, and the hypoxia was evaluated in situ by injecting chicks with hypoxyprobe-1 at 40 mg/kg. After 60 min they were euthanized and the tibial growth plates were immunostained with antibodies that recognized hypoxyprobe adducts (arrows). A = control; B = control with quercetin at 100 ppm; C, control with quercetin at 500 ppm; D, thiram at 40 ppm; E, thiram with quercetin at 100 ppm; F, thiram with quercetin at 500 ppm. BV = blood vessels. Magnification × 100. Color version available in the online PDF. observed in mammals (Glaze et al., 2005) . Another possible explanation for the difference between the mammalian and avian Hsp90 responses to 17-DMAG may lie in the dissimilarity between their respective Hsp90 genes. In the chicken, 4 Hsp90 genes have been reported, of which some appear to be heat-shock inducible and some to be expressed constitutively. Comparative studies between chickens and Japanese quail have revealed novel characteristics common to birds and differences between avian species and other vertebrates (Iwamoto et al., 2008; Nagahori et al., 2010) . Moreover, the patterns of expression of the various Hsp90 genes may differ among different tissues and species.
Among Hsp90 clients are regulators of angiogenesis, such as HIF-1α, VEGF, and VEGF receptors. The VEGF/VEGF-receptor system is a key regulator of angiogenesis during skeletal growth in both normal and pathological situations (Ferrara et al., 2003) . Recently we demonstrated that in dyschondroplasic growth plates Hsp90 inhibition did not affect VEGF levels whereas it upregulated the VEGF receptor Flk-1 (Herzog et al., 2011) . The finding that low doses of 17-DMAG increased Flk-1 levels ( Figure 4 ) without any signs of improvements in TD score, TD lesion width (Table 1) , or angiogenesis (Figure 3) suggests that Flk-1 is not the only limiting factor in TD prevention by Hsp90-inhibition. The list of Hsp90 client proteins includes many kinases and transcription factors as well as other molecules known to be involved in cell proliferation, differentiation, apoptosis, survival, and migration (Zhang and Burrows, 2004) ; therefore, it cannot be ruled out that inhibition of Hsp90 might have affected other, as yet unknown client proteins involved in vascularization, differentiation, and survival of chondrocytes within the growth plates.
Quercetin was used to confirm the central role of Hsp90 in development of the TD lesion. Quercetin did not affect growth-plate levels of Hsp90 in either the control or the TD-afflicted chicks, but it reduced Hsp70 levels in control chicks and prevented upregulation of Hsp70 in the growth plates of the thiram-treated chicks ( Figure 5 ), confirming its role as an inhibitor of Hsp70 synthesis. In contrast to the effects of 17-DMAG, quercetin did not reduce TD scores or lesion widths and did not improve angiogenesis, and the chicks did not recover their ability to stand properly (Table 1; Figure 6 ). Moreover, quercetin caused mild hypoxia in the control chicks and did not prevent the increased hypoxia observed in the dyschondroplasic growth plate (Figure 7 ).
In conclusion, this study supports the major role of Hsp90 in chondrocyte differentiation and vascularization of the avian growth plate. In contrast to the anti-angiogenic effects of Hsp90 inhibitors observed in mammalian tissues, inhibition of Hsp90 activity in the TD-afflicted chicks resulted in activation of the angiogenic switch, restoration of normal growth-plate morphology, and prevention of lameness.
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